Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 471.67B | -1.58%365.78B | 6.60%1.7T | 8.20%445.7B | 10.21%371.66B | 9.74%1.59T | 7.95%398.32B | 10.41%444.27B | 7.55%411.92B | 13.92%337.22B |
| Cost of revenue | 293.17B | -2.31%227.1B | 4.81%1.05T | 6.94%273.1B | 9.16%232.47B | 11.57%1T | 9.16%254.5B | 10.01%278.89B | 10.75%255.37B | 17.90%212.97B |
| Gross profit | 178.5B | -0.37%138.68B | 9.64%646.88B | 10.26%172.61B | 12.03%139.19B | 6.78%590B | 5.86%143.83B | 11.08%165.38B | 2.72%156.55B | 7.70%124.25B |
| Operating expense | 123.64B | 5.60%111.65B | 8.60%486.77B | 10.16%125.32B | 7.47%105.73B | 8.47%448.24B | 6.68%118.73B | 2.54%117.36B | 21.42%113.76B | 4.90%98.39B |
| Selling and administrative expenses | --123.91B | 4.08%110.32B | 7.31%477.97B | 9.86%124.82B | 8.21%106B | 5.99%445.4B | 7.37%116.62B | 8.10%117.2B | 3.86%113.62B | 4.43%97.96B |
| -General and administrative expense | --123.91B | 4.08%110.32B | 7.31%477.97B | 9.86%124.82B | 8.21%106B | 5.99%445.4B | 7.37%116.62B | 8.10%117.2B | 3.86%113.62B | 4.43%97.96B |
| Other operating expenses | --1.07B | 73.26%2.41B | 127.54%13.91B | 34.85%1.28B | 28.08%1.39B | -50.59%6.11B | -16.82%3.05B | -85.32%1.04B | -5.77%947M | 66.06%1.09B |
| Total other operating income | --1.34B | -34.70%1.08B | 56.06%5.11B | -4.08%775M | 151.52%1.66B | -83.11%3.27B | -4.59%935M | -13.62%869M | -95.17%808M | -1.64%660M |
| Operating profit | 54.85B | -19.22%27.03B | 12.95%160.11B | 10.52%47.28B | 29.37%33.46B | 1.78%141.75B | 2.18%25.09B | 39.49%48.01B | -27.13%42.78B | 19.83%25.86B |
| Net non-operating interest income (expenses) | 31M | -173.55%-570M | 1,350.91%798M | -135.49%-137M | 445.77%775M | 113.85%55M | -146.10%-662M | 419.44%187M | 1,386.67%386M | 205.97%142M |
| Non-operating interest income | --688M | -52.70%842M | 29.67%5.55B | 17.85%1.22B | 123.34%1.78B | 162.80%4.28B | 356.91%1.12B | 140.40%1.33B | 127.59%1.03B | 111.41%797M |
| Non-operating interest expense | --657M | 40.50%1.41B | 12.47%4.75B | 109.61%1.35B | 53.44%1.01B | 108.59%4.23B | 246.80%1.79B | 120.93%1.14B | 33.54%645M | 28.18%655M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -120M | -34.62%272M | 614.81%139M | 30.65%-224M | -17.95%416M | -106.57%-27M | -179.19%-137M | -143.71%-73M | -1,213.79%-323M | 1,167.50%507M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 54.77B | -22.85%26.73B | 13.59%161.05B | 9.51%46.92B | 30.69%34.65B | 1.79%141.78B | -0.68%24.29B | 39.00%48.13B | -27.03%42.85B | 23.38%26.51B |
| Income tax | 14.94B | -27.52%6.36B | 16.40%43.42B | 5.99%13.54B | 23.51%8.77B | -2.33%37.3B | -35.78%3.52B | 30.97%13.91B | -23.61%12.77B | 32.08%7.1B |
| Net income | 39.83B | -21.28%20.37B | 12.59%117.63B | 11.01%33.38B | 33.32%25.88B | 3.34%104.48B | 9.43%20.78B | 42.55%34.22B | -28.39%30.07B | 20.48%19.41B |
| Net income continuous operations | --39.83B | -21.27%20.37B | 12.59%117.63B | 11.00%33.38B | 33.31%25.88B | 3.34%104.48B | 9.43%20.78B | 42.55%34.22B | -28.39%30.07B | 20.47%19.41B |
| Noncontrolling interests | 5.6B | -11.91%4.96B | 11.03%24.13B | 13.67%7.14B | 16.60%5.63B | 15.73%21.74B | 10.94%5.2B | 14.97%5.42B | 11.96%6.28B | 28.30%4.82B |
| Net income attributable to the company | 34.23B | -23.88%15.42B | 12.99%93.5B | 10.31%26.24B | 38.85%20.25B | 0.52%82.74B | 8.93%15.57B | 49.30%28.79B | -34.62%23.79B | 18.10%14.59B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 34.23B | -23.88%15.42B | 12.99%93.5B | 10.31%26.24B | 38.85%20.25B | 0.52%82.74B | 8.93%15.57B | 49.30%28.79B | -34.62%23.79B | 18.10%14.59B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 110.77 | -23.87%49.9 | 12.99%302.57 | 10.30%84.92 | 38.85%65.55 | 0.52%267.78 | 8.93%50.4 | 49.30%93.18 | -34.62%76.99 | 18.11%47.21 |
| Diluted earnings per share | 110.7671 | -23.87%49.9 | 12.99%302.57 | 10.30%84.92 | 38.85%65.55 | 0.52%267.78 | 8.93%50.4 | 49.30%93.18 | -34.62%76.99 | 18.11%47.21 |
| Dividend per share | 0 | 0 | 50.00%120 | 37.50%55 | 0 | 0.00%80 | -2.44%40 | 0 | 2.56%40 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |